THC
TENET HEALTHCARE CORP
Company overview
- Market capitalization
- $20.77B
- Employees
- 77,000
- Latest publication
- 2026-09-29
About TENET HEALTHCARE CORP
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20102010-09-30 · USD | Q2 20072007-06-30 · USD | Q4 20022002-12-31 · USD | Q3 20022002-09-30 · USD | Q1 20012001-03-31 · USD | Q4 20002000-12-31 · USD | Q3 20002000-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,628,000,000USD | 2,262,000,000USD | 2,228,000,000USD | 3,778,000,000USD | 3,703,000,000USD | 3,036,000,000USD | 2,915,000,000USD | 2,893,000,000USD |
| Other Operating Expenses | 2,348,000,000USD | — | — | — | — | — | — | — |
| Operating Income | 1,501,000,000USD | 102,000,000USD | 58,000,000USD | 645,000,000USD | 624,000,000USD | 439,000,000USD | 401,000,000USD | 380,000,000USD |
| Total Other Income Expense Net | -226,000,000USD | -164,000,000USD | -91,000,000USD | -129,000,000USD | -68,000,000USD | -107,000,000USD | -109,000,000USD | -123,000,000USD |
| Interest Expense | 204,000,000USD | 107,000,000USD | 86,000,000USD | 187,000,000USD | 65,000,000USD | 98,000,000USD | 96,000,000USD | 117,000,000USD |
| Labor And Related Expense | 2,231,000,000USD | — | — | — | — | — | — | — |
| Litigation Settlement Expense | 3,000,000USD | — | — | — | — | — | — | — |
| Income Before Tax | 1,275,000,000USD | -62,000,000USD | -33,000,000USD | 516,000,000USD | 556,000,000USD | 332,000,000USD | 292,000,000USD | 257,000,000USD |
| Income Tax Expense | 295,000,000USD | -1,002,000,000USD | -4,000,000USD | 201,000,000USD | 218,000,000USD | 134,000,000USD | 117,000,000USD | 103,000,000USD |
| Equity Method Income Loss | 65,000,000USD | — | — | — | — | — | — | — |
| Net Income | 1,045,000,000USD | 938,000,000USD | -30,000,000USD | 315,000,000USD | 338,000,000USD | 198,000,000USD | 175,000,000USD | 154,000,000USD |
| Minority Interest | 219,000,000USD | 2,000,000USD | — | 5,000,000USD | 9,000,000USD | 1,000,000USD | 3,000,000USD | 4,000,000USD |
| Net Income Applicable To Common Shares | 826,000,000USD | 932,000,000USD | — | — | 315,000,000USD | 151,000,000USD | 198,000,000USD | 175,000,000USD |
| Cost Of Revenue | — | 1,367,000,000USD | 1,392,000,000USD | 1,265,000,000USD | 1,247,000,000USD | 1,061,000,000USD | 1,042,000,000USD | 1,040,000,000USD |
| Gross Profit | — | 895,000,000USD | 836,000,000USD | 2,513,000,000USD | 2,456,000,000USD | 1,975,000,000USD | 1,873,000,000USD | 1,853,000,000USD |
| Research Development | — | 0USD | — | — | — | — | — | — |
| Selling General Administrative | — | 1,482,000,000USD | 680,000,000USD | 1,738,000,000USD | 1,700,000,000USD | 1,397,000,000USD | 1,336,000,000USD | 1,336,000,000USD |
| Unclassified Operating Expenses | — | -689,000,000USD | 98,000,000USD | 130,000,000USD | 132,000,000USD | 139,000,000USD | 136,000,000USD | 137,000,000USD |
| Total Operating Expenses | — | 793,000,000USD | 778,000,000USD | 1,868,000,000USD | 1,832,000,000USD | 1,536,000,000USD | 1,472,000,000USD | 1,473,000,000USD |
| Net Income From Continuing Ops | — | 940,000,000USD | — | — | — | — | — | — |
| Ebit | — | 45,000,000USD | 58,000,000USD | 645,000,000USD | 624,000,000USD | 439,000,000USD | 401,000,000USD | 380,000,000USD |
| Ebitda | — | 146,000,000USD | 147,000,000USD | 775,000,000USD | 752,000,000USD | 578,000,000USD | 537,000,000USD | 517,000,000USD |
| Depreciation And Amortization | — | 101,000,000USD | 89,000,000USD | 130,000,000USD | 128,000,000USD | 139,000,000USD | 136,000,000USD | 137,000,000USD |
| Reconciled Depreciation | — | 101,000,000USD | 89,000,000USD | 122,000,000USD | 130,000,000USD | 139,000,000USD | 136,000,000USD | 137,000,000USD |
| Non Operating Income Net Other | — | -52,000,000USD | — | — | — | — | — | — |
| Discontinued Operations | — | -1,000,000USD | — | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20102010-12-31 · USD | FY 19981998-12-31 · USD | FY 19911991-12-31 · USD | FY 19891989-12-31 · USD | FY 19881988-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 8,265,000,000USD | 10,880,000,000USD | 3,761,800,000USD | 3,806,000,000USD | 3,935,000,000USD |
| Cost Of Revenue | 1,542,000,000USD | 3,867,000,000USD | 3,163,000,000USD | 3,065,000,000USD | 3,252,000,000USD |
| Gross Profit | 6,723,000,000USD | 7,013,000,000USD | 598,800,000USD | 741,000,000USD | 683,000,000USD |
| Research Development | 0USD | — | — | — | — |
| Selling General Administrative | 5,838,000,000USD | 4,640,000,000USD | — | — | — |
| Unclassified Operating Expenses | 251,000,000USD | 2,373,000,000USD | 598,800,000USD | 741,000,000USD | 683,000,000USD |
| Total Operating Expenses | 6,089,000,000USD | 7,013,000,000USD | 598,800,000USD | 741,000,000USD | 683,000,000USD |
| Operating Income | 634,000,000USD | 1,302,000,000USD | 399,800,000USD | 569,000,000USD | 513,000,000USD |
| Interest Expense | 424,000,000USD | 1,035,000,000USD | 497,000,000USD | 78,000,000USD | 132,000,000USD |
| Income Before Tax | 158,000,000USD | 474,000,000USD | 259,000,000USD | 472,000,000USD | 405,000,000USD |
| Income Tax Expense | -977,000,000USD | 225,000,000USD | 99,000,000USD | 195,000,000USD | 163,000,000USD |
| Net Income | 1,143,000,000USD | 249,000,000USD | 160,000,000USD | 277,000,000USD | 242,000,000USD |
| Net Income From Continuing Ops | 1,135,000,000USD | — | — | — | — |
| Ebit | 537,000,000USD | 1,398,000,000USD | 402,800,000USD | 571,000,000USD | 526,000,000USD |
| Ebitda | 962,000,000USD | 1,858,000,000USD | 598,800,000USD | 741,000,000USD | 683,000,000USD |
| Depreciation And Amortization | 425,000,000USD | 460,000,000USD | 196,000,000USD | 170,000,000USD | 157,000,000USD |
| Total Other Income Expense Net | -476,000,000USD | -828,000,000USD | -140,800,000USD | -97,000,000USD | -108,000,000USD |
| Non Operating Income Net Other | -52,000,000USD | — | — | — | — |
| Minority Interest | 9,000,000USD | — | — | — | — |
| Discontinued Operations | 17,000,000USD | — | — | — | — |
| Net Income Applicable To Common Shares | 1,119,000,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 30,676,000,000USD | 31,203,000,000USD | 29,677,000,000USD | 29,418,000,000USD | 28,699,000,000USD | 29,237,000,000USD | 28,936,000,000USD | 29,372,000,000USD |
| Cash And Equivalents | 2,170,000,000USD | — | 2,883,000,000USD | 2,975,000,000USD | 2,625,000,000USD | 2,999,000,000USD | 3,019,000,000USD | 4,094,000,000USD |
| Total Current Assets | 7,827,000,000USD | 8,356,000,000USD | 7,849,000,000USD | 7,810,000,000USD | 7,298,000,000USD | 7,913,000,000USD | 7,682,000,000USD | 8,759,000,000USD |
| Other Current Assets | 2,649,000,000USD | 2,441,000,000USD | 2,053,000,000USD | 711,000,000USD | 634,000,000USD | 1,418,000,000USD | 1,263,000,000USD | 1,256,000,000USD |
| Total Liabilities | 21,976,000,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,567,000,000USD | 6,152,000,000USD | 4,463,000,000USD | 4,560,000,000USD | 4,271,000,000USD | 4,451,000,000USD | 4,310,000,000USD | 5,538,000,000USD |
| Other Current Liabilities | 2,698,000,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 1,777,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 4,658,000,000USD | 4,814,000,000USD | 4,220,000,000USD | 4,014,000,000USD | 3,749,000,000USD | 4,181,000,000USD | 4,171,000,000USD | 3,834,000,000USD |
| Total Equity Including Noncontrolling Interest | 8,700,000,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 13,088,000,000USD | 13,128,000,000USD | 13,092,000,000USD | 13,102,000,000USD | 13,091,000,000USD | 13,082,000,000USD | 13,081,000,000USD | 12,776,000,000USD |
| Net Receivables | 2,608,000,000USD | 2,605,000,000USD | 2,565,000,000USD | 3,778,000,000USD | 3,701,000,000USD | 3,152,000,000USD | 3,054,000,000USD | 3,053,000,000USD |
| Inventory | 338,000,000USD | 343,000,000USD | 348,000,000USD | 346,000,000USD | 338,000,000USD | 344,000,000USD | 346,000,000USD | 356,000,000USD |
| Property Plant Equipment Net | 6,258,000,000USD | 6,251,000,000USD | 7,449,000,000USD | 6,091,000,000USD | 6,024,000,000USD | 5,991,000,000USD | 7,086,000,000USD | 5,552,000,000USD |
| Goodwill | 11,437,000,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 1,281,000,000USD | 1,316,000,000USD | 1,348,000,000USD | 1,348,000,000USD | 1,372,000,000USD | 1,400,000,000USD | 1,397,000,000USD | 1,373,000,000USD |
| Accounts Payable | 1,371,000,000USD | 1,339,000,000USD | 1,360,000,000USD | 1,356,000,000USD | 1,360,000,000USD | 1,327,000,000USD | 1,294,000,000USD | 1,265,000,000USD |
| Common Stock | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD |
| Retained Earnings | 5,943,000,000USD | 5,117,000,000USD | 4,415,000,000USD | 4,044,000,000USD | 3,702,000,000USD | 3,414,000,000USD | 3,008,000,000USD | 2,690,000,000USD |
| Accumulated Other Comprehensive Income | -177,000,000USD | -179,000,000USD | -181,000,000USD | -174,000,000USD | -177,000,000USD | -178,000,000USD | -180,000,000USD | -175,000,000USD |
| Total Liab | — | 22,353,000,000USD | 20,704,000,000USD | 20,718,000,000USD | 20,397,000,000USD | 20,584,000,000USD | 20,389,000,000USD | 21,297,000,000USD |
| Other Current Liab | — | 4,496,000,000USD | 3,024,000,000USD | 3,091,000,000USD | 2,802,000,000USD | 2,887,000,000USD | 2,906,000,000USD | 3,352,000,000USD |
| Capital Stock | — | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD |
| Good Will | — | 11,387,000,000USD | 11,198,000,000USD | 11,158,000,000USD | 10,935,000,000USD | 10,786,000,000USD | 10,691,000,000USD | 10,588,000,000USD |
| Cash | — | 2,967,000,000USD | 2,883,000,000USD | 2,975,000,000USD | 2,625,000,000USD | 2,999,000,000USD | 3,019,000,000USD | 4,094,000,000USD |
| Cash And Short Term Investments | — | 2,967,000,000USD | 2,883,000,000USD | 2,975,000,000USD | 2,625,000,000USD | 2,999,000,000USD | 3,019,000,000USD | 4,094,000,000USD |
| Net Debt | — | 10,242,000,000USD | 10,288,000,000USD | 10,212,000,000USD | 10,550,000,000USD | 10,171,000,000USD | 10,154,000,000USD | 8,777,000,000USD |
| Short Term Debt | — | 81,000,000USD | 79,000,000USD | 85,000,000USD | 84,000,000USD | 88,000,000USD | 92,000,000USD | 95,000,000USD |
| Short Long Term Debt | — | 81,000,000USD | 79,000,000USD | 85,000,000USD | 84,000,000USD | 88,000,000USD | 92,000,000USD | 95,000,000USD |
| Short Long Term Debt Total | — | 13,209,000,000USD | 13,171,000,000USD | 13,187,000,000USD | 13,175,000,000USD | 13,170,000,000USD | 13,173,000,000USD | 12,871,000,000USD |
| Property Plant Equipment Gross | — | 13,065,000,000USD | 14,129,000,000USD | 12,287,000,000USD | 12,120,000,000USD | 11,935,000,000USD | 12,895,000,000USD | 11,266,000,000USD |
| Common Stock Shares Outstanding | — | 87,596,000shares | 87,917,000shares | 88,610,000shares | 91,791,000shares | 95,019,000shares | 95,882,000shares | 96,652,000shares |
| Non Current Assets Total | — | 22,847,000,000USD | 21,828,000,000USD | 21,608,000,000USD | 21,401,000,000USD | 21,324,000,000USD | 21,254,000,000USD | 20,613,000,000USD |
| Non Current Liabilities Total | — | 16,201,000,000USD | 16,241,000,000USD | 16,158,000,000USD | 16,126,000,000USD | 16,133,000,000USD | 16,079,000,000USD | 15,759,000,000USD |
| Non Current Liabilities Other | — | 1,693,000,000USD | 1,713,000,000USD | 1,600,000,000USD | 1,635,000,000USD | 1,651,000,000USD | 1,573,000,000USD | 1,560,000,000USD |
| Non Currrent Assets Other | — | 922,000,000USD | 307,000,000USD | 2,939,000,000USD | 2,994,000,000USD | 78,000,000USD | 194,000,000USD | 2,710,000,000USD |
| Net Working Capital | — | 2,204,000,000USD | 3,386,000,000USD | 3,250,000,000USD | 3,027,000,000USD | 3,462,000,000USD | 3,372,000,000USD | 3,221,000,000USD |
| Unclassified Non Current Assets | — | 2,971,000,000USD | — | — | — | 2,991,000,000USD | 274,000,000USD | 354,000,000USD |
| Unclassified Current Liabilities | — | 155,000,000USD | -79,000,000USD | -57,000,000USD | -59,000,000USD | 61,000,000USD | -74,000,000USD | 650,000,000USD |
| Unclassified Non Current Liabilities | — | 1,380,000,000USD | 1,436,000,000USD | 1,456,000,000USD | 1,400,000,000USD | 1,400,000,000USD | 1,425,000,000USD | 1,423,000,000USD |
| Unclassified Equity | — | -140,000,000USD | — | 128,000,000USD | 208,000,000USD | 929,000,000USD | 1,327,000,000USD | 1,303,000,000USD |
| Other Assets | — | — | 84,000,000USD | 72,000,000USD | 76,000,000USD | 78,000,000USD | 80,000,000USD | 36,000,000USD |
| Long Term Investments | — | — | 1,442,000,000USD | — | — | — | 1,532,000,000USD | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | 81,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 29,677,000,000USD | 28,936,000,000USD | 28,312,000,000USD | 27,156,000,000USD | 27,579,000,000USD | 27,106,000,000USD | 23,351,000,000USD | 22,409,000,000USD |
| Intangible Assets | 1,348,000,000USD | 1,397,000,000USD | 1,368,000,000USD | 1,424,000,000USD | 1,497,000,000USD | 1,600,000,000USD | 1,602,000,000USD | 1,731,000,000USD |
| Other Current Assets | 2,053,000,000USD | 1,263,000,000USD | 2,124,000,000USD | 1,256,000,000USD | 1,021,000,000USD | 982,000,000USD | 1,245,000,000USD | 827,000,000USD |
| Total Liab | 20,704,000,000USD | 20,389,000,000USD | 22,804,000,000USD | 22,548,000,000USD | 23,322,000,000USD | 24,217,000,000USD | 21,362,000,000USD | 20,302,000,000USD |
| Total Stockholder Equity | 4,220,000,000USD | 4,171,000,000USD | 1,608,000,000USD | 1,142,000,000USD | 1,028,000,000USD | 28,000,000USD | -371,000,000USD | -119,000,000USD |
| Other Current Liab | 3,024,000,000USD | 2,702,000,000USD | 3,209,000,000USD | 2,717,000,000USD | 2,715,000,000USD | 2,836,000,000USD | 2,769,000,000USD | 2,582,000,000USD |
| Common Stock | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD |
| Capital Stock | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 8,000,000USD | 7,000,000USD | 7,000,000USD | 7,000,000USD |
| Retained Earnings | 4,415,000,000USD | 3,008,000,000USD | -192,000,000USD | -803,000,000USD | -1,214,000,000USD | -2,128,000,000USD | -2,467,000,000USD | -2,236,000,000USD |
| Good Will | 11,198,000,000USD | 10,691,000,000USD | 10,307,000,000USD | 10,123,000,000USD | 9,261,000,000USD | 8,808,000,000USD | 7,252,000,000USD | 7,281,000,000USD |
| Other Assets | 84,000,000USD | 128,000,000USD | 120,000,000USD | 19,000,000USD | 65,000,000USD | 325,000,000USD | 646,000,000USD | 772,000,000USD |
| Cash | 2,883,000,000USD | 3,019,000,000USD | 1,228,000,000USD | 858,000,000USD | 2,364,000,000USD | 2,446,000,000USD | 262,000,000USD | 411,000,000USD |
| Cash And Equivalents | 2,883,000,000USD | 3,019,000,000USD | 1,228,000,000USD | 858,000,000USD | 2,364,000,000USD | 2,446,000,000USD | 262,000,000USD | 411,000,000USD |
| Cash And Short Term Investments | 2,883,000,000USD | 3,019,000,000USD | 1,228,000,000USD | 858,000,000USD | 2,364,000,000USD | 2,446,000,000USD | 262,000,000USD | 411,000,000USD |
| Total Current Assets | 7,849,000,000USD | 7,682,000,000USD | 7,167,000,000USD | 5,981,000,000USD | 7,075,000,000USD | 7,147,000,000USD | 5,081,000,000USD | 4,636,000,000USD |
| Total Current Liabilities | 4,463,000,000USD | 4,310,000,000USD | 4,760,000,000USD | 4,476,000,000USD | 5,109,000,000USD | 4,847,000,000USD | 4,205,000,000USD | 3,857,000,000USD |
| Net Debt | 10,288,000,000USD | 11,308,000,000USD | 13,774,000,000USD | 14,221,000,000USD | 13,282,000,000USD | 13,273,000,000USD | 14,489,000,000USD | 14,415,000,000USD |
| Short Term Debt | 79,000,000USD | 296,000,000USD | 120,000,000USD | 145,000,000USD | 135,000,000USD | 145,000,000USD | 171,000,000USD | 182,000,000USD |
| Short Long Term Debt | 79,000,000USD | 92,000,000USD | 120,000,000USD | 145,000,000USD | 135,000,000USD | 145,000,000USD | 171,000,000USD | 182,000,000USD |
| Short Long Term Debt Total | 13,171,000,000USD | 14,327,000,000USD | 15,002,000,000USD | 15,079,000,000USD | 15,646,000,000USD | 15,719,000,000USD | 14,751,000,000USD | 14,826,000,000USD |
| Long Term Debt | 13,092,000,000USD | 13,081,000,000USD | 14,882,000,000USD | 14,934,000,000USD | 15,511,000,000USD | 15,574,000,000USD | 14,580,000,000USD | 14,644,000,000USD |
| Long Term Investments | 1,442,000,000USD | 1,532,000,000USD | 1,560,000,000USD | 3,147,000,000USD | 3,254,000,000USD | 2,534,000,000USD | 2,369,000,000USD | 1,456,000,000USD |
| Net Receivables | 2,565,000,000USD | 3,054,000,000USD | 3,404,000,000USD | 3,462,000,000USD | 3,306,000,000USD | 3,351,000,000USD | 3,264,000,000USD | 3,093,000,000USD |
| Inventory | 348,000,000USD | 346,000,000USD | 411,000,000USD | 405,000,000USD | 384,000,000USD | 368,000,000USD | 310,000,000USD | 305,000,000USD |
| Accounts Payable | 1,360,000,000USD | 1,294,000,000USD | 1,408,000,000USD | 1,504,000,000USD | 1,300,000,000USD | 1,207,000,000USD | 1,204,000,000USD | 1,093,000,000USD |
| Property Plant Equipment Net | 7,449,000,000USD | 7,086,000,000USD | 7,319,000,000USD | 7,591,000,000USD | 7,429,000,000USD | 7,754,000,000USD | 7,790,000,000USD | 6,993,000,000USD |
| Property Plant Equipment Gross | 14,129,000,000USD | 12,895,000,000USD | 13,797,000,000USD | 13,792,000,000USD | 13,509,000,000USD | 7,884,000,000USD | 7,959,000,000USD | 7,148,000,000USD |
| Accumulated Other Comprehensive Income | -181,000,000USD | -180,000,000USD | -181,000,000USD | -181,000,000USD | -233,000,000USD | -281,000,000USD | -257,000,000USD | -223,000,000USD |
| Common Stock Shares Outstanding | 90,833,000shares | 97,881,000shares | 104,800,000shares | 110,516,000shares | 108,571,000shares | 106,263,000shares | 103,398,000shares | 103,881,000shares |
| Non Current Assets Total | 21,828,000,000USD | 21,254,000,000USD | 21,145,000,000USD | 21,175,000,000USD | 20,504,000,000USD | 19,959,000,000USD | 18,270,000,000USD | 17,773,000,000USD |
| Non Current Liabilities Total | 16,241,000,000USD | 16,079,000,000USD | 18,044,000,000USD | 18,072,000,000USD | 18,213,000,000USD | 19,370,000,000USD | 17,157,000,000USD | 16,445,000,000USD |
| Non Current Liabilities Other | 1,713,000,000USD | 1,573,000,000USD | 1,709,000,000USD | 1,787,000,000USD | 1,439,000,000USD | 3,767,000,000USD | 2,550,000,000USD | 1,765,000,000USD |
| Non Currrent Assets Other | 307,000,000USD | 194,000,000USD | 180,000,000USD | 192,000,000USD | 224,000,000USD | 239,000,000USD | 264,000,000USD | 229,000,000USD |
| Net Working Capital | 3,386,000,000USD | 3,372,000,000USD | 2,407,000,000USD | 1,505,000,000USD | 1,966,000,000USD | 2,300,000,000USD | 876,000,000USD | 779,000,000USD |
| Unclassified Current Liabilities | -79,000,000USD | -74,000,000USD | -156,000,000USD | -145,000,000USD | -135,000,000USD | -145,000,000USD | -171,000,000USD | -1,476,000,000USD |
| Unclassified Non Current Liabilities | 1,436,000,000USD | 1,425,000,000USD | 1,453,000,000USD | -958,000,000USD | -1,475,000,000USD | -3,796,000,000USD | -1,719,000,000USD | -1,801,000,000USD |
| Short Term Investments | — | 1,505,000,000USD | — | -1,518,000,000USD | -1,439,000,000USD | 2,534,000USD | — | -460,000,000USD |
| Unclassified Current Assets | — | -1,505,000,000USD | — | 858,000,000USD | 1,439,000,000USD | — | — | 411,000,000USD |
| Unclassified Non Current Assets | — | 226,000,000USD | 291,000,000USD | -1,321,000,000USD | -1,226,000,000USD | -1,301,000,000USD | -1,653,000,000USD | -689,000,000USD |
| Unclassified Equity | — | 1,327,000,000USD | 1,965,000,000USD | 2,110,000,000USD | 4,869,000,000USD | 4,837,000,000USD | 4,753,000,000USD | 4,740,000,000USD |
| Current Deferred Revenue | — | — | 59,000,000USD | 110,000,000USD | 959,000,000USD | 659,000,000USD | 61,000,000USD | 1,294,000,000USD |
| Deferred Long Term Liab | — | — | — | 217,000,000USD | 36,000,000USD | 29,000,000USD | 27,000,000USD | 36,000,000USD |
| Other Liab | — | — | — | 2,092,000,000USD | 2,702,000,000USD | 3,796,000,000USD | 1,719,000,000USD | 1,801,000,000USD |
| Net Tangible Assets | — | — | — | -8,256,000,000USD | -9,730,000,000USD | -8,428,000,000USD | -7,719,000,000USD | -7,711,000,000USD |
| Treasury Stock | — | — | — | — | -2,410,000,000USD | -2,414,000,000USD | -2,414,000,000USD | -2,414,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 444,000,000USD |
| Stock Based Compensation | 69,000,000USD |
| Deferred Income Tax | 97,000,000USD |
| Other Non Cash Items | 10,000,000USD |
| Change To Account Receivables | -33,000,000USD |
| Change To Liabilities | -602,000,000USD |
| Change In Working Capital | -635,000,000USD |
| Operating Cash Flow | 2,226,000,000USD |
| Capital Expenditures | -348,000,000USD |
| Net Investments | -77,000,000USD |
| Other Investing Activities | -108,000,000USD |
| Unclassified Investing Cash Flow | 13,000,000USD |
| Investing Cash Flow | -520,000,000USD |
| Net Debt Issuance | -31,000,000USD |
| Net Common Stock Issuance | -1,443,000,000USD |
| Other Financing Activities | -562,000,000USD |
| Unclassified Financing Cash Flow | -383,000,000USD |
| Financing Cash Flow | -2,419,000,000USD |
| Change In Cash | -713,000,000USD |
| End Cash Flow | 2,170,000,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 906,000,000USD | 371,000,000USD | 579,000,000USD | 522,000,000USD | 622,000,000USD | 572,000,000USD | 681,000,000USD | 477,000,000USD |
| Depreciation | 229,000,000USD | 236,000,000USD | 218,000,000USD | 208,000,000USD | 206,000,000USD | 193,000,000USD | 209,000,000USD | 208,000,000USD |
| Stock Based Compensation | 25,000,000USD | 25,000,000USD | 38,000,000USD | 20,000,000USD | 21,000,000USD | 15,000,000USD | 16,000,000USD | 19,000,000USD |
| Other Non Cash Items | 28,000,000USD | 203,000,000USD | -11,000,000USD | 35,000,000USD | -9,000,000USD | -18,000,000USD | -375,000,000USD | -62,000,000USD |
| Change To Account Receivables | -28,000,000USD | -48,000,000USD | 28,000,000USD | 109,000,000USD | -69,000,000USD | 62,000,000USD | 106,000,000USD | 340,000,000USD |
| Change To Inventory | 407,000,000USD | -15,000,000USD | -9,000,000USD | 117,000,000USD | -108,000,000USD | -96,000,000USD | -6,000,000USD | 34,000,000USD |
| Change In Working Capital | 493,000,000USD | -104,000,000USD | 194,000,000USD | 144,000,000USD | -29,000,000USD | -1,019,000,000USD | 450,000,000USD | 160,000,000USD |
| Total Cash From Operating Activities | 1,641,000,000USD | 731,000,000USD | 1,058,000,000USD | 936,000,000USD | 815,000,000USD | -331,000,000USD | 1,045,000,000USD | 747,000,000USD |
| Capital Expenditures | -180,000,000USD | -364,000,000USD | -280,000,000USD | -193,000,000USD | -173,000,000USD | -330,000,000USD | -206,000,000USD | -145,000,000USD |
| Free Cash Flow | 1,461,000,000USD | 367,000,000USD | 778,000,000USD | 743,000,000USD | 642,000,000USD | -661,000,000USD | 839,000,000USD | 602,000,000USD |
| Investments | -4,000,000USD | -2,000,000USD | -385,000,000USD | -314,000,000USD | -187,000,000USD | -372,000,000USD | 667,000,000USD | -194,000,000USD |
| Total Cashflows From Investing Activities | -317,000,000USD | -389,000,000USD | -385,000,000USD | -314,000,000USD | -187,000,000USD | -372,000,000USD | 667,000,000USD | -194,000,000USD |
| Net Borrowings | -19,000,000USD | -27,000,000USD | -22,000,000USD | -16,000,000USD | -31,000,000USD | -24,000,000USD | -25,000,000USD | — |
| Total Cash From Financing Activities | -1,240,000,000USD | -434,000,000USD | -323,000,000USD | -996,000,000USD | -648,000,000USD | -372,000,000USD | -498,000,000USD | -154,000,000USD |
| Sale Purchase Of Stock | -318,000,000USD | -202,000,000USD | -93,000,000USD | -747,000,000USD | -348,000,000USD | 672,000,000USD | -124,000,000USD | -270,000,000USD |
| Change In Cash | 84,000,000USD | -92,000,000USD | 350,000,000USD | -374,000,000USD | -20,000,000USD | -1,075,000,000USD | 1,214,000,000USD | 399,000,000USD |
| Begin Period Cash Flow | 2,883,000,000USD | 2,975,000,000USD | 2,625,000,000USD | 2,999,000,000USD | 3,019,000,000USD | 4,094,000,000USD | 2,880,000,000USD | 2,481,000,000USD |
| End Period Cash Flow | 2,967,000,000USD | 2,883,000,000USD | 2,975,000,000USD | 2,625,000,000USD | 2,999,000,000USD | 3,019,000,000USD | 4,094,000,000USD | 2,880,000,000USD |
| Other Cashflows From Investing Activities | -12,000,000USD | 19,000,000USD | -258,000,000USD | -3,000,000USD | 16,000,000USD | 15,000,000USD | 909,000,000USD | 18,000,000USD |
| Other Cashflows From Financing Activities | -903,000,000USD | -205,000,000USD | -208,000,000USD | -233,000,000USD | -269,000,000USD | -1,020,000,000USD | -349,000,000USD | 148,000,000USD |
| Unclassified Operating Cash Flow | -40,000,000USD | — | 40,000,000USD | — | — | -74,000,000USD | 64,000,000USD | -55,000,000USD |
| Unclassified Investing Cash Flow | -121,000,000USD | -42,000,000USD | 538,000,000USD | 196,000,000USD | 157,000,000USD | 315,000,000USD | -703,000,000USD | 127,000,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | -32,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,407,000,000USD | 4,064,000,000USD | 1,311,000,000USD | 1,001,000,000USD | 1,476,000,000USD | 768,000,000USD | 171,000,000USD | 459,000,000USD |
| Depreciation | 886,000,000USD | 818,000,000USD | 870,000,000USD | 841,000,000USD | 855,000,000USD | 857,000,000USD | 850,000,000USD | 802,000,000USD |
| Stock Based Compensation | 104,000,000USD | 67,000,000USD | 66,000,000USD | 56,000,000USD | 56,000,000USD | 44,000,000USD | 42,000,000USD | 46,000,000USD |
| Other Non Cash Items | 1,187,000,000USD | -2,935,000,000USD | 4,000,000USD | 119,000,000USD | -332,000,000USD | 274,000,000USD | 344,000,000USD | -41,000,000USD |
| Change To Account Receivables | 20,000,000USD | 245,000,000USD | -29,000,000USD | -140,000,000USD | -197,000,000USD | 195,000,000USD | -247,000,000USD | -134,000,000USD |
| Change To Inventory | -73,000,000USD | -86,000,000USD | -139,000,000USD | -64,000,000USD | -52,000,000USD | -145,000,000USD | -94,000,000USD | 17,000,000USD |
| Change In Working Capital | -44,000,000USD | 136,000,000USD | 71,000,000USD | -1,143,000,000USD | -737,000,000USD | 1,592,000,000USD | -318,000,000USD | -364,000,000USD |
| Total Cash From Operating Activities | 3,540,000,000USD | 2,047,000,000USD | 2,374,000,000USD | 1,083,000,000USD | 1,568,000,000USD | 3,407,000,000USD | 1,233,000,000USD | 1,049,000,000USD |
| Capital Expenditures | -1,010,000,000USD | -931,000,000USD | -751,000,000USD | -762,000,000USD | -658,000,000USD | -540,000,000USD | -670,000,000USD | -617,000,000USD |
| Free Cash Flow | 2,530,000,000USD | 1,116,000,000USD | 1,623,000,000USD | 321,000,000USD | 910,000,000USD | 2,867,000,000USD | 563,000,000USD | 432,000,000USD |
| Investments | 3,000,000USD | 3,429,000,000USD | -942,000,000USD | -808,000,000USD | -714,000,000USD | -44,000,000USD | -62,000,000USD | -127,000,000USD |
| Total Cashflows From Investing Activities | -1,275,000,000USD | 3,429,000,000USD | -969,000,000USD | -808,000,000USD | -714,000,000USD | -1,608,000,000USD | -619,000,000USD | -115,000,000USD |
| Net Borrowings | -96,000,000USD | -2,220,000,000USD | -172,000,000USD | -852,000,000USD | -349,000,000USD | 477,000,000USD | -482,000,000USD | -289,000,000USD |
| Total Cash From Financing Activities | -2,401,000,000USD | -3,685,000,000USD | -1,035,000,000USD | -1,781,000,000USD | -936,000,000USD | 385,000,000USD | -763,000,000USD | -1,134,000,000USD |
| Sale Purchase Of Stock | -1,437,000,000USD | -672,000,000USD | -200,000,000USD | -250,000,000USD | -2,000,000USD | 185,000,000USD | 22,000,000USD | -611,000,000USD |
| Change In Cash | -136,000,000USD | 1,791,000,000USD | 370,000,000USD | -1,506,000,000USD | -82,000,000USD | 2,184,000,000USD | -149,000,000USD | -200,000,000USD |
| Begin Period Cash Flow | 3,019,000,000USD | 1,228,000,000USD | 858,000,000USD | 2,364,000,000USD | 2,446,000,000USD | 262,000,000USD | 411,000,000USD | 611,000,000USD |
| End Period Cash Flow | 2,883,000,000USD | 3,019,000,000USD | 1,228,000,000USD | 858,000,000USD | 2,364,000,000USD | 2,446,000,000USD | 262,000,000USD | 411,000,000USD |
| Other Cashflows From Investing Activities | 40,000,000USD | 4,962,000,000USD | 60,000,000USD | 204,000,000USD | 1,241,000,000USD | 94,000,000USD | 56,000,000USD | 564,000,000USD |
| Other Cashflows From Financing Activities | -868,000,000USD | -793,000,000USD | -663,000,000USD | -703,000,000USD | -587,000,000USD | -163,000,000USD | -293,000,000USD | -845,000,000USD |
| Unclassified Investing Cash Flow | -308,000,000USD | -4,031,000,000USD | 664,000,000USD | 558,000,000USD | -583,000,000USD | -1,118,000,000USD | 57,000,000USD | 65,000,000USD |
| Unclassified Operating Cash Flow | — | -103,000,000USD | 52,000,000USD | 209,000,000USD | 250,000,000USD | -128,000,000USD | 144,000,000USD | 147,000,000USD |
| Change To Liabilities | — | — | — | -913,000,000USD | -584,000,000USD | 1,523,000,000USD | 39,000,000USD | -254,000,000USD |
| Dividends Paid | — | — | — | -560,000,000USD | -423,000,000USD | -287,000,000USD | -307,000,000USD | -288,000,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -1,506,000,000USD | -82,000,000USD | 2,184,000,000USD | -149,000,000USD | -200,000,000USD |
| Unclassified Financing Cash Flow | — | — | — | 584,000,000USD | 425,000,000USD | 173,000,000USD | 297,000,000USD | 899,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Segment | Ambulatory Care | 1,388,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Hospital Operations | 4,240,000,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Segment | Ambulatory Care | 1,320,000,000 | USD | 0000070318-26-000026 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Hospital Operations | 4,048,000,000 | USD | 0000070318-26-000026 |
| Q4 2025Quarterly · 2025-12-31 | Segment | Ambulatory Care | 1,433,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Hospital Operations | 4,094,000,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Segment | Ambulatory Care | 5,172,000,000 | USD | 0000070318-26-000012 |
| FY 2025Yearly · 2025-12-31 | Segment | Hospital Operations | 16,138,000,000 | USD | 0000070318-26-000012 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Ambulatory Care | 1,275,000,000 | USD | 0000070318-25-000046 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Hospital Operations | 4,014,000,000 | USD | 0000070318-25-000046 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Ambulatory Care | 1,270,000,000 | USD | 0000070318-25-000039 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Hospital Operations | 4,001,000,000 | USD | 0000070318-25-000039 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Ambulatory Care | 1,194,000,000 | USD | 0000070318-26-000026 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Hospital Operations | 4,029,000,000 | USD | 0000070318-26-000026 |
| Q4 2024Quarterly · 2024-12-31 | Segment | Ambulatory Care | 1,259,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Hospital Operations | 3,814,000,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Segment | Ambulatory Care | 4,534,000,000 | USD | 0000070318-26-000012 |
| FY 2024Yearly · 2024-12-31 | Segment | Hospital Operations | 16,141,000,000 | USD | 0000070318-26-000012 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Ambulatory Care | 1,139,000,000 | USD | 0000070318-25-000046 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Hospital Operations | 3,987,000,000 | USD | 0000070318-25-000046 |
| FY 2023Yearly · 2023-12-31 | Segment | Ambulatory Care | 3,865,000,000 | USD | 0000070318-26-000012 |
| FY 2023Yearly · 2023-12-31 | Segment | Hospital Operations | 16,698,000,000 | USD | 0000070318-26-000012 |
| FY 2022Yearly · 2022-12-31 | Segment | Ambulatory Care | 3,248,000,000 | USD | 0000070318-25-000009 |
| FY 2022Yearly · 2022-12-31 | Segment | Hospital Operations | 15,926,000,000 | USD | 0000070318-25-000009 |
| FY 2021Yearly · 2021-12-31 | Segment | Ambulatory Care | 2,718,000,000 | USD | 0000070318-24-000016 |
| FY 2021Yearly · 2021-12-31 | Segment | Hospital Operations | 16,767,000,000 | USD | 0000070318-24-000016 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.